Park Square has placed Alexandra Joseph, Ph.D., as Chief Scientific Officer at Photys Therapeutics.
Photys Therapeutics, a pioneer in the development of phosphorylationinducing chimeric small molecule medicines (PHICS), announced the appointment of Dr. Alexandra Joseph as Chief Scientific Officer.
https://www.photys.com/_files/ugd/8c4eaf_9dd260065abe4457a3d8600088d3a874.pdf